124 related articles for article (PubMed ID: 24548695)
21. Anti-inflammatory effect of antidiabetic thiazolidinediones prevents bone resorption rather than cartilage changes in experimental polyarthritis.
Koufany M; Moulin D; Bianchi A; Muresan M; Sebillaud S; Netter P; Weryha G; Jouzeau JY
Arthritis Res Ther; 2008; 10(1):R6. PubMed ID: 18199331
[TBL] [Abstract][Full Text] [Related]
22. A novel selective peroxisome proliferator-activator receptor-gamma modulator-SPPARgammaM5 improves insulin sensitivity with diminished adverse cardiovascular effects.
Chang CH; McNamara LA; Wu MS; Muise ES; Tan Y; Wood HB; Meinke PT; Thompson JR; Doebber TW; Berger JP; McCann ME
Eur J Pharmacol; 2008 Apr; 584(1):192-201. PubMed ID: 18346728
[TBL] [Abstract][Full Text] [Related]
23. Rosiglitazone, a peroxisome proliferator-activated receptor γ stimulant, abrogates diabetes-evoked hypertension by rectifying abnormalities in vascular reactivity.
El-Bassossy HM; Abo-Warda SM; Fahmy A
Clin Exp Pharmacol Physiol; 2012 Aug; 39(8):643-9. PubMed ID: 22594672
[TBL] [Abstract][Full Text] [Related]
24. Rosiglitazone (peroxisome proliferator-activated receptor-gamma) counters hypertension and adverse cardiac and vascular remodeling in 2K1C hypertensive rats.
Silva-Junior Gde O; Torres Tda S; Mendonca Lde S; Mandarim-de-Lacerda CA
Exp Toxicol Pathol; 2011 Jan; 63(1-2):1-7. PubMed ID: 19775877
[TBL] [Abstract][Full Text] [Related]
25. Rosiglitazone attenuates atrial structural remodeling and atrial fibrillation promotion in alloxan-induced diabetic rabbits.
Liu T; Zhao H; Li J; Korantzopoulos P; Li G
Cardiovasc Ther; 2014 Aug; 32(4):178-83. PubMed ID: 24814361
[TBL] [Abstract][Full Text] [Related]
26. PPAR gamma agonists partially restores hyperglycemia induced aggravation of vascular dysfunction to angiotensin II in thoracic aorta isolated from rats with insulin resistance.
Gaikwad AB; Viswanad B; Ramarao P
Pharmacol Res; 2007 May; 55(5):400-7. PubMed ID: 17369046
[TBL] [Abstract][Full Text] [Related]
27. Serum cardiac troponin I concentrations transiently increase in rats given rosiglitazone.
Mikaelian I; Buness A; Hirkaler G; Fernandes R; Coluccio D; Geng W; Visalli T; Bachynsky MO; Berkofsky-Fessler W; Kanwal C; Hilton H; Nicklaus R; Hoflack JC; Dunn M; Sanders M; Giron M; Boyle BW; Singer T; Dick LS
Toxicol Lett; 2011 Mar; 201(2):110-5. PubMed ID: 21172411
[TBL] [Abstract][Full Text] [Related]
28. Effects of rosiglitazone and aspirin on experimental model of induced type 2 diabetes in rats: focus on insulin resistance and inflammatory markers.
Abdin AA; Baalash AA; Hamooda HE
J Diabetes Complications; 2010; 24(3):168-78. PubMed ID: 19328014
[TBL] [Abstract][Full Text] [Related]
29. Pharmacogenomic, physiological, and biochemical investigations on safety and efficacy biomarkers associated with the peroxisome proliferator-activated receptor-gamma activator rosiglitazone in rodents: a translational medicine investigation.
Wang X; Liu X; Zhan Y; Lavallie ER; Diblasio-Smith L; Collins-Racie L; Mounts WM; Rutkowski JL; Xu X; Goltsman I; Abassi Z; Winaver J; Feuerstein GZ
J Pharmacol Exp Ther; 2010 Sep; 334(3):820-9. PubMed ID: 20519551
[TBL] [Abstract][Full Text] [Related]
30. Modulation of cardiac and aortic peroxisome proliferator-activated receptor-gamma expression by oxidative stress in chronically glucose-fed rats.
El Midaoui A; Wu L; Wang R; de Champlain J
Am J Hypertens; 2006 Apr; 19(4):407-12. PubMed ID: 16580578
[TBL] [Abstract][Full Text] [Related]
31. Effect of berberine on PPARalpha/delta/gamma expression in type 2 diabetic rat retinae.
Zhou JY; Zhou SW
Yao Xue Xue Bao; 2007 Dec; 42(12):1243-9. PubMed ID: 18338635
[TBL] [Abstract][Full Text] [Related]
32. Reduced cardiotropic response to insulin in spontaneously hypertensive rats: role of peroxisome proliferator-activated receptor-gamma-initiated signaling.
Zhang H; Li J; Li R; Zhang Q; Ma H; Ji Q; Guo W; Wang H; Lopez BL; Christopher TA; Ma X; Gao F
J Hypertens; 2008 Mar; 26(3):560-9. PubMed ID: 18300869
[TBL] [Abstract][Full Text] [Related]
33. Ameliorative role of rosiglitazone in hyperhomocysteinemia-induced experimental cardiac hypertrophy.
Pal Singh A; Kaur T; SinghDahiya R; Singh N; Singh Bedi PM
J Cardiovasc Pharmacol; 2010 Jul; 56(1):53-9. PubMed ID: 20351560
[TBL] [Abstract][Full Text] [Related]
34. Apoptosis and proliferation of cultured mesangial cells isolated from kidneys of rosiglitazone-treated pregnant diabetic rats.
Weissgarten J; Berman S; Efrati S; Rapoport M; Averbukh Z; Feldman L
Nephrol Dial Transplant; 2006 May; 21(5):1198-204. PubMed ID: 16449288
[TBL] [Abstract][Full Text] [Related]
35. Influence of the peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist, rosiglitazone and antagonist, biphenol-A-diglicydyl ether (BADGE) on the course of inflammation in the experimental model of colitis in rats.
Dworzanski T; Celinski K; Korolczuk A; Slomka M; Radej S; Czechowska G; Madro A; Cichoz-Lach H
J Physiol Pharmacol; 2010 Dec; 61(6):683-93. PubMed ID: 21224499
[TBL] [Abstract][Full Text] [Related]
36. PPARγ agonist improves neuronal insulin receptor function in hippocampus and brain mitochondria function in rats with insulin resistance induced by long term high-fat diets.
Pipatpiboon N; Pratchayasakul W; Chattipakorn N; Chattipakorn SC
Endocrinology; 2012 Jan; 153(1):329-38. PubMed ID: 22109891
[TBL] [Abstract][Full Text] [Related]
37. Effects of rosiglitazone and interactions with growth-regulating factors in ventricular cell hypertrophy.
Bell D; McDermott BJ
Eur J Pharmacol; 2005 Jan; 508(1-3):69-76. PubMed ID: 15680255
[TBL] [Abstract][Full Text] [Related]
38. Rosiglitazone reverses cardiac adverse remodeling (fibrosis and vascularization) in perinatal low protein rat offspring.
Torres Tda S; Aguila MB; Mandarim-de-Lacerda CA
Pathol Res Pract; 2010 Sep; 206(9):642-6. PubMed ID: 20447773
[TBL] [Abstract][Full Text] [Related]
39. Peroxisome proliferator activated receptor (PPAR)alpha agonists inhibit hypertrophy of neonatal rat cardiac myocytes.
Liang F; Wang F; Zhang S; Gardner DG
Endocrinology; 2003 Sep; 144(9):4187-94. PubMed ID: 12933694
[TBL] [Abstract][Full Text] [Related]
40. Cardioprotective role of peroxisome proliferator-activated receptor-γ agonist, rosiglitazone in a unique murine model of diabetic cardiopathy.
Giri SR; Bhoi B; Jain MR; Gatne MM
Life Sci; 2016 Oct; 162():1-13. PubMed ID: 27530514
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
